OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 122 filers reported holding OCULAR THERAPEUTIX INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $733 | +19.4% | 233,582 | +96.4% | 0.06% | +3.3% |
| Q2 2023 | $614 | -99.9% | 118,953 | -7.1% | 0.06% | -20.8% |
| Q2 2022 | $514,000 | +80.4% | 127,978 | +122.1% | 0.08% | +102.6% |
| Q1 2022 | $285,000 | +738.2% | 57,620 | +413.5% | 0.04% | +660.0% |
| Q3 2019 | $34,000 | -66.7% | 11,222 | -28.1% | 0.01% | 0.0% |
| Q1 2018 | $102,000 | -60.9% | 15,600 | +25.7% | 0.01% | -50.0% |
| Q2 2015 | $261,000 | – | 12,412 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $19,223 | 100.00% |
| Opaleye Management Inc. | 6,468,000 | $20,309,520 | 6.61% |
| DELTEC ASSET MANAGEMENT LLC | 2,061,797 | $6,474,043 | 1.48% |
| Endurant Capital Management LP | 353,707 | $1,110,640 | 1.00% |
| SECTORAL ASSET MANAGEMENT INC | 969,350 | $3,043,759 | 0.59% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $609,995 | 0.09% |
| Covestor Ltd | 37,404 | $117 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 233,582 | $733 | 0.06% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 342,111 | $1,074,229 | 0.03% |
| Polar Asset Management Partners Inc. | 263,763 | $828,216 | 0.02% |